Books > Reference & Interdisciplinary > Interdisciplinary studies > Globalization
|
Buy Now
Pills for the Poorest - An Exploration of TRIPS and Access to Medication in Sub-Saharan Africa (Hardcover)
Loot Price: R3,175
Discovery Miles 31 750
|
|
Pills for the Poorest - An Exploration of TRIPS and Access to Medication in Sub-Saharan Africa (Hardcover)
Series: Palgrave Socio-Legal Studies
Expected to ship within 12 - 17 working days
|
Donate to Against Period Poverty
Total price: R3,195
Discovery Miles: 31 950
|
The desperate need for a vast part of the global population to
access better medicines in more certain ways is one of the biggest
concerns of the modern era.
"Pills for the Poorest" offers a new perspective on the
much-debated issue of the links between intellectual property and
access to medication. Using ethnographic case studies in Djibouti
and Ghana, and insights from actor-network theory, it explores the
ways in which TRIPs and pharmaceutical patents are translated in
the daily practices of those who purchase, distribute, and use (or
fail to use) medicines in sub-Saharan Africa. It suggests that
focusing on routine practices and the material deployment of
intellectual property significantly enriches our understanding of
the complex dynamics that animate the field of access to medicines
and helps relocate the role of law within those processes. It
demonstrates how intellectual property affects access to medicines
in ways that are often discreet, indirect and forgotten. By
exploring these complex mechanisms, it seeks to ask questions about
the modes of actions of pharmaceutical patents, but also, more
generally, about the complexity of legal objects.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.